Nomura Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.4M | Sell |
42,310
-11,624
| -22% | -$7.91M | 0.06% | 293 |
|
|
2026
Q1 | $41.7M | Buy |
53,934
+517
| +1% | +$396K | 0.11% | 201 |
|
|
2025
Q4 | $41.2M | Sell |
53,417
-374
| -0.7% | -$254K | 0.1% | 206 |
|
|
2025
Q3 | $30.2M | Sell |
53,791
-2,223
| -4% | -$1.26M | 0.08% | 247 |
|
|
2025
Q2 | $29.4M | Sell |
56,014
-37,278
| -40% | -$20.8M | 0.08% | 258 |
|
|
2025
Q1 | $59.2M | Buy |
93,292
+778
| +0.8% | +$535K | 0.18% | 129 |
|
|
2024
Q4 | $65.9M | Buy |
92,514
+6,510
| +8% | +$5.46M | 0.2% | 111 |
|
|
2024
Q3 | $90.4M | Buy |
86,004
+3,698
| +4% | +$4.12M | 0.28% | 80 |
|
|
2024
Q2 | $86.5M | Buy |
82,306
+6,978
| +9% | +$6.76M | 0.29% | 72 |
|
|
2024
Q1 | $72.5M | Buy |
75,328
+16,405
| +28% | +$15.6M | 0.26% | 82 |
|
|
2023
Q4 | $51.8M | Buy |
58,923
+1,439
| +3% | +$1.19M | 0.21% | 114 |
|
|
2023
Q3 | $47.3M | Buy |
57,484
+1,671
| +3% | +$1.31M | 0.22% | 108 |
|
|
2023
Q2 | $40.1M | Sell |
55,813
-1,556
| -3% | -$1.2M | 0.18% | 128 |
|
|
2023
Q1 | $47.1M | Sell |
57,369
-9,684
| -14% | -$7.3M | 0.25% | 96 |
|
|
2022
Q4 | $48.4M | Sell |
67,053
-2,159
| -3% | -$1.59M | 0.28% | 84 |
|
|
2022
Q3 | $47.7M | Sell |
69,212
-5,034
| -7% | -$3.17M | 0.3% | 74 |
|
|
2022
Q2 | $43.9M | Buy |
74,246
+14,676
| +25% | +$9.54M | 0.27% | 84 |
|
|
2022
Q1 | $41.6M | Buy |
59,570
+1,817
| +3% | +$1.15M | 0.23% | 98 |
|
|
2021
Q4 | $36.5M | Buy |
57,753
+3,409
| +6% | +$2.1M | 0.18% | 119 |
|
|
2021
Q3 | $32.9M | Sell |
54,344
-11,836
| -18% | -$7.35M | 0.19% | 120 |
|
|
2021
Q2 | $37M | Sell |
66,180
-2,253
| -3% | -$1.14M | 0.21% | 111 |
|
|
2021
Q1 | $32.4M | Buy |
68,433
+9,818
| +17% | +$4.78M | 0.21% | 109 |
|
|
2020
Q4 | $28.3M | Buy |
58,615
+7,283
| +14% | +$3.93M | 0.19% | 117 |
|
|
2020
Q3 | $28.7M | Buy |
51,332
+2,873
| +6% | +$1.74M | 0.22% | 100 |
|
|
2020
Q2 | $30.2M | Buy |
48,459
+23,358
| +93% | +$13.3M | 0.26% | 88 |
|
|
2020
Q1 | $12.3M | Sell |
25,101
-941
| -4% | -$388K | 0.13% | 167 |
|
|
2019
Q4 | $9.78M | Buy |
26,042
+2,123
| +9% | +$714K | 0.09% | 228 |
|
|
2019
Q3 | $6.63M | Buy |
23,919
+2,894
| +14% | +$856K | 0.06% | 280 |
|
|
2019
Q2 | $6.58M | Sell |
21,025
-124,395
| -86% | -$41.4M | 0.07% | 266 |
|
|
2019
Q1 | $59.7M | Buy |
145,420
+128,551
| +762% | +$52.9M | 0.59% | 37 |
|
|
2018
Q4 | $6.3M | Sell |
16,869
-459
| -3% | -$168K | 0.07% | 246 |
|
|
2018
Q3 | $7M | Sell |
17,328
-1,126
| -6% | -$429K | 0.07% | 246 |
|
|
2018
Q2 | $6.37M | Buy |
18,454
+516
| +3% | +$161K | 0.07% | 250 |
|
|
2018
Q1 | $6.18M | Buy |
17,938
+436
| +2% | +$152K | 0.07% | 250 |
|
|
2017
Q4 | $6.58M | Buy |
17,502
+492
| +3% | +$199K | 0.08% | 231 |
|
|
2017
Q3 | $7.61M | Buy |
17,010
+151
| +0.9% | +$71.9K | 0.1% | 198 |
|
|
2017
Q2 | $8.28M | Buy |
16,859
+621
| +4% | +$272K | 0.11% | 186 |
|
|
2017
Q1 | $6.29M | Buy |
16,238
+229
| +1% | +$84.9K | 0.09% | 229 |
|
|
2016
Q4 | $5.88M | Sell |
16,009
-1,369
| -8% | -$521K | 0.11% | 219 |
|
|
2016
Q3 | $6.99M | Buy |
17,378
+1,827
| +12% | +$733K | 0.13% | 190 |
|
|
2016
Q2 | $5.43M | Sell |
15,551
-3,367
| -18% | -$1.3M | 0.1% | 210 |
|
|
2016
Q1 | $6.82M | Buy |
18,918
+6,881
| +57% | +$2.84M | 0.13% | 178 |
|
|
2015
Q4 | $6.54M | Sell |
12,037
-528
| -4% | -$286K | 0.13% | 183 |
|
|
2015
Q3 | $5.84M | Buy |
12,565
+347
| +3% | +$186K | 0.12% | 193 |
|
|
2015
Q2 | $6.23M | Sell |
12,218
-287
| -2% | -$140K | 0.12% | 182 |
|
|
2015
Q1 | $5.65M | Buy |
12,505
+266
| +2% | +$113K | 0.1% | 200 |
|
|
2014
Q4 | $5M | Sell |
12,239
-125
| -1% | -$49.2K | 0.09% | 226 |
|
|
2014
Q3 | $4.46M | Buy |
12,364
+706
| +6% | +$237K | 0.08% | 236 |
|
|
2014
Q2 | $3.29M | Buy |
11,658
+636
| +6% | +$188K | 0.06% | 288 |
|
|
2014
Q1 | $3.31M | Sell |
11,022
-1,513
| -12% | -$466K | 0.06% | 286 |
|
|
2013
Q4 | $3.45M | Buy |
12,535
+630
| +5% | +$181K | 0.06% | 279 |
|
|
2013
Q3 | $3.73M | Buy |
11,905
+14
| +0.1% | +$3.68K | 0.07% | 262 |
|
|
2013
Q2 | $2.67M | Buy |
+11,891
| New | +$2.77M | 0.05% | 345 |
|
Other funds holding REGN
Nomura Asset Management's REGN Position: Q2 2026 in Review
Nomura Asset Management reduced its Regeneron Pharmaceuticals (REGN) stake by 22% in Q2 2026, selling an estimated $7.91M and leaving 42,310 shares worth $26.4M. The position accounts for 0.06% of the portfolio, ranked #293.
Nomura Asset Management first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $90.4M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Nomura Asset Management held 42,310 shares of Regeneron Pharmaceuticals worth $26.4M as of Q2 2026.
- Nomura Asset Management sold 11,624 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $7.91M.
- Regeneron Pharmaceuticals made up 0.06% of Nomura Asset Management's portfolio in Q2 2026, its #293 holding.
- Nomura Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Nomura Asset Management's Regeneron Pharmaceuticals position peaked at $90.4M in Q3 2024.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.